Skip to Content

N23 (Neggram 1 GM)

Generic Name: nalidixic acid

Pill with imprint N23 is Yellow, Elliptical / Oval and has been identified as Neggram 1 GM. It is supplied by Sanofi-Synthelabo Inc.

NegGram is used in the treatment of bladder infection; prevention of bladder infection and belongs to the drug classes quinolones, urinary anti-infectives. Risk cannot be ruled out during pregnancy. NegGram 1 GM is not a controlled substance under the Controlled Substance Act (CSA).

Images for N23

Neggram

Generic Name:
nalidixic acid
Imprint:
N23
Strength:
1 GM
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Quinolones
Urinary anti-infectives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sanofi-Synthelabo Inc
National Drug Code (NDC):
00024-1323

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide